BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24517998)

  • 1. Genetic variants of the Wnt signaling pathway as predictors of recurrence and survival in early-stage non-small cell lung cancer patients.
    Coscio A; Chang DW; Roth JA; Ye Y; Gu J; Yang P; Wu X
    Carcinogenesis; 2014 Jun; 35(6):1284-91. PubMed ID: 24517998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
    Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
    Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variations in epigenetic genes are predictors of recurrence in stage I or II non-small cell lung cancer patients.
    Wagner KW; Ye Y; Lin J; Vaporciyan AA; Roth JA; Wu X
    Clin Cancer Res; 2012 Jan; 18(2):585-92. PubMed ID: 22252258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I-III Non-Small-Cell Lung Cancer.
    Glubb DM; Paré-Brunet L; Jantus-Lewintre E; Jiang C; Crona D; Etheridge AS; Mirza O; Zhang W; Seiser EL; Rzyman W; Jassem J; Auman T; Hirsch FR; Owzar K; Camps C; Dziadziuszko R; Innocenti F
    J Thorac Oncol; 2015 Jul; 10(7):1067-75. PubMed ID: 26134224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide analysis of survival in early-stage non-small-cell lung cancer.
    Huang YT; Heist RS; Chirieac LR; Lin X; Skaug V; Zienolddiny S; Haugen A; Wu MC; Wang Z; Su L; Asomaning K; Christiani DC
    J Clin Oncol; 2009 Jun; 27(16):2660-7. PubMed ID: 19414679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genetic variation in microRNA target site of KRT81 gene is associated with survival in early-stage non-small-cell lung cancer.
    Lee SY; Choi JE; Jeon HS; Hong MJ; Choi YY; Kang HG; Yoo SS; Lee EB; Jeong JY; Lee WK; Lee J; Cha SI; Kim CH; Kim YT; Jheon S; Son JW; Park JY
    Ann Oncol; 2015 Jun; 26(6):1142-1148. PubMed ID: 25716425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt signaling pathway pharmacogenetics in non-small cell lung cancer.
    Stewart DJ; Chang DW; Ye Y; Spitz M; Lu C; Shu X; Wampfler JA; Marks RS; Garces YI; Yang P; Wu X
    Pharmacogenomics J; 2014 Dec; 14(6):509-22. PubMed ID: 24980784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.
    Wu X; Ye Y; Rosell R; Amos CI; Stewart DJ; Hildebrandt MA; Roth JA; Minna JD; Gu J; Lin J; Buch SC; Nukui T; Ramirez Serrano JL; Taron M; Cassidy A; Lu C; Chang JY; Lippman SM; Hong WK; Spitz MR; Romkes M; Yang P
    J Natl Cancer Inst; 2011 May; 103(10):817-25. PubMed ID: 21483023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentially functional variants of HBEGF and ITPR3 in GnRH signaling pathway genes predict survival of non-small cell lung cancer patients.
    Wu Y; Liu Z; Tang D; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Lin L; Christiani DC; Wang Q; Wei Q
    Transl Res; 2021 Jul; 233():92-103. PubMed ID: 33400994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of HIF1A gene are associated with prognosis of early stage non-small-cell lung cancer patients after surgery.
    Liu B; Liu Q; Song Y; Li X; Wang Y; Wan S; Zhang Z; Su H
    Med Oncol; 2014 Apr; 31(4):877. PubMed ID: 24567056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt pathway activation predicts increased risk of tumor recurrence in patients with stage I nonsmall cell lung cancer.
    Shapiro M; Akiri G; Chin C; Wisnivesky JP; Beasley MB; Weiser TS; Swanson SJ; Aaronson SA
    Ann Surg; 2013 Mar; 257(3):548-54. PubMed ID: 23011390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Variants in the Wnt Signaling Pathway Are Not Associated with Survival Outcome of Non-Small Cell Lung Cancer in a Korean Population.
    Yoo SS; Hong MJ; Choi JE; Lee JH; Baek SA; Lee WK; Lee SY; Lee SY; Lee J; Cha SI; Kim CH; Cho S; Park JY
    J Korean Med Sci; 2016 Mar; 31(3):463-6. PubMed ID: 26955250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
    Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
    Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
    Yoon KA; Yoon H; Park S; Jang HJ; Zo JI; Lee HS; Lee JS
    J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common genetic variants in cell cycle pathway are associated with survival in stage III-IV non-small-cell lung cancer.
    Yin J; Lu C; Gu J; Lippman SM; Hildebrandt MA; Lin J; Stewart D; Spitz MR; Wu X
    Carcinogenesis; 2011 Dec; 32(12):1867-71. PubMed ID: 21965272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetic variations in DNA repair genes ERCC2 and XRCC1 were associated with the overall survival of advanced non-small-cell lung cancer patients.
    Wang S; Wang J; Bai Y; Wang Q; Liu L; Zhang K; Hong X; Deng Q; Zhang X; He M; Wu T; Xu P; Guo H
    Cancer Med; 2016 Sep; 5(9):2332-42. PubMed ID: 27465648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentially functional genetic variants in PLIN2, SULT2A1 and UGT1A9 genes of the ketone pathway and survival of nonsmall cell lung cancer.
    Tang D; Zhao YC; Liu H; Luo S; Clarke JM; Glass C; Su L; Shen S; Christiani DC; Gao W; Wei Q
    Int J Cancer; 2020 Sep; 147(6):1559-1570. PubMed ID: 32072637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variations in the regulator of G-protein signaling genes are associated with survival in late-stage non-small cell lung cancer.
    Dai J; Gu J; Lu C; Lin J; Stewart D; Chang D; Roth JA; Wu X
    PLoS One; 2011; 6(6):e21120. PubMed ID: 21698121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-related single-nucleotide polymorphism of XPO5 is strongly correlated with the prognosis and chemotherapy response in advanced non-small-cell lung cancer patients.
    Geng JQ; Wang XC; Li LF; Zhao J; Wu S; Yu GP; Zhu KJ
    Tumour Biol; 2016 Feb; 37(2):2257-65. PubMed ID: 26358254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial.
    Guo Y; Feng Y; Liu H; Luo S; Clarke JW; Moorman PG; Su L; Shen S; Christiani DC; Wei Q
    Mol Carcinog; 2019 Jul; 58(7):1094-1104. PubMed ID: 30989732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.